Morality and Access to Essential Medicines: Pairing the Theoretical and Practical

&
Developing World Bioethics 24 (1):3-5 (2024)
  Copy   BIBTEX

Abstract

Developing World Bioethics, EarlyView.

Categories

Keywords

Reprint years

DOI

10.1111/dewb.12445

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Global Health Impact: Extending Access to Essential Medicines.Nicole Hassoun - 2020 - Oup Usa.
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Global Pharmaceutical Markets.Kevin Outterson & Donald W. Light - 2009 - In Helga Kuhse & Peter Singer (eds.), A Companion to Bioethics. Oxford, UK: Wiley‐Blackwell. pp. 417–429.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Montréal Statement on the Human Right to Essential Medicines.Thomas Pogge - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (1):97-108.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.
Law, Politics, and Access to Essential Medicines in Developing Countries.Heinz Klug - 2008 - Politics and Society 36 (2):207-245.
Nicole Hassoun: Global Health Impact: Extending Access to Essential Medicines, 2020. [REVIEW]Michael Da Silva - 2021 - Ethical Theory and Moral Practice 24 (1):419-421.
The ‘access to medicines’ campaign vs. big pharma: Counter-hegemonic discourse change and the political economy of hiv/aids medicines.Thomas Owen - 2014 - Critical Discourse Studies 11 (3):288-304.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Transparency in Medicines Regulatory Affairs Reclaiming Missed Opportunities.Y. A. Vawda & A. Gray - 2017 - South African Journal of Bioethics and Law 10 (2):69-74.
Enhancing Global Health Impact—Beyond the Basic Minimum, Metrics and Ethical Consumption.Nicole Hassoun - 2022 - Public Health Ethics 15 (2):138-146.
Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.

Analytics

Added to PP
2024-02-09

Downloads
18 (#836,872)

6 months
18 (#144,337)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Andreas Albertsen
Aarhus University
Michael Da Da Silva
University of Toronto

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references